Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP

Business Wire December 19, 2022

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

Business Wire November 28, 2022

ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP

Business Wire November 16, 2022

ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues

Business Wire November 9, 2022

ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET

Business Wire October 24, 2022

ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer

Business Wire September 12, 2022

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Business Wire August 30, 2022

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

Business Wire August 29, 2022

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP

Business Wire August 16, 2022

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

Business Wire August 8, 2022

ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

Business Wire August 3, 2022

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

Business Wire July 28, 2022

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

Business Wire July 25, 2022

ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary

Business Wire July 18, 2022

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

Business Wire June 22, 2022

ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients

PR Newswire June 21, 2022

ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition

Business Wire June 2, 2022

ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP

Business Wire June 1, 2022

ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

Business Wire May 20, 2022

ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

Business Wire May 10, 2022